Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

被引：194
作者：
Yuan, Xun [1 ]
Wu, Hua [1 ]
Han, Na [1 ]
Xu, Hanxiao [1 ]
Chu, Qian [1 ]
Yu, Shiying [1 ]
Chen, Yuan [1 ]
Wu, Kongming [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Bldg 303,1095 Jie Fang Ave, Wuhan 430030, Peoples R China
来源：
JOURNAL OF HEMATOLOGY & ONCOLOGY | 2014年 / 7卷
基金：
美国国家科学基金会;
关键词：
Notch signaling; Epithelial-mesenchymal transition (EMT); Cancer stem cells (CSCs); Non-small-cell lung cancer (NSCLC); Gamma secretase inhibitor; EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-SECRETASE INHIBITOR; CYCLIN D1; TGF-BETA; POOR-PROGNOSIS; TUMOR-GROWTH; STEM-CELLS; E-CADHERIN; IN-VITRO; PHASE-I;
D O I：
10.1186/s13045-014-0087-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Through epithelial-mesenchymal transition (EMT), cancer cells acquire enhanced ability of migration and invasion, stem cell like characteristics and therapeutic resistance. Notch signaling regulates cell-cell connection, cell polarity and motility during organ development. Recent studies demonstrate that Notch signaling plays an important role in lung cancer initiation and cross-talks with several transcriptional factors to enhance EMT, contributing to the progression of non-small cell lung cancer (NSCLC). Correspondingly, blocking of Notch signaling inhibits NSCLC migration and tumor growth by reversing EMT. Clinical trials have showed promising effect in some cancer patients received treatment with Notch1 inhibitor. This review attempts to provide an overview of the Notch signal in NSCLC: its biological significance and therapeutic application.
引用
收藏
页数：10
相关论文
共 118 条
[71]  
Messersmith WA, 2014, CLIN CANC RES
[72]   γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer [J].
Mizugaki, H. ;
Sakakibara-Konishi, J. ;
Ikezawa, Y. ;
Kikuchi, J. ;
Kikuchi, E. ;
Oizumi, S. ;
Dang, T. P. ;
Nishimura, M. .
BRITISH JOURNAL OF CANCER, 2012, 106 (12) :1953-1959
[73]   The Gamma Secretase Inhibitor MRK-003 Attenuates Pancreatic Cancer Growth in Preclinical Models [J].
Mizuma, Masamichi ;
Rasheed, Zeshaan A. ;
Yabuuchi, Shinichi ;
Omura, Noriyuki ;
Campbell, Nathaniel R. ;
de Wilde, Roeland F. ;
De Oliveira, Elizabeth ;
Zhang, Qing ;
Puig, Oscar ;
Matsui, William ;
Hidalgo, Manuel ;
Maitra, Anirban ;
Rajeshkumar, N. V. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (09) :1999-2009
[74]   Slug is a direct Notch target required for initiation of cardiac cushion cellularization [J].
Niessen, Kyle ;
Fu, YangXin ;
Chang, Linda ;
Hoodless, Pamela A. ;
McFadden, Deborah ;
Karsan, Aly .
JOURNAL OF CELL BIOLOGY, 2008, 182 (02) :315-325
[75]   Jagged/Notch signalling is required for a subset of TGFβ1 responses in human kidney epithelial cells [J].
Nyhan, Kristine C. ;
Faherty, Noel ;
Murray, Gregg ;
Cooey, Laurence Berube ;
Godson, Catherine ;
Crean, John K. ;
Brazil, Derek P. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (12) :1386-1395
[76]   Dynamic Changes in Intracellular ROS Levels Regulate Airway Basal Stem Cell Homeostasis through Nrf2-Dependent Notch Signaling [J].
Paul, Manash K. ;
Bisht, Bharti ;
Darmawan, Daphne O. ;
Chiou, Richard ;
Ha, Vi L. ;
Wallace, William D. ;
Chon, Andrew T. ;
Hegab, Ahmed E. ;
Grogan, Tristan ;
Elashoff, David A. ;
Alva-Ornelas, Jackelyn A. ;
Gomperts, Brigitte N. .
CELL STEM CELL, 2014, 15 (02) :199-214
[77]   MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma [J].
Ramakrishnan, V. ;
Ansell, S. ;
Haug, J. ;
Grote, D. ;
Kimlinger, T. ;
Stenson, M. ;
Timm, M. ;
Wellik, L. ;
Halling, T. ;
Rajkumar, S. V. ;
Kumar, S. .
LEUKEMIA, 2012, 26 (02) :340-348
[78]  
Rampias T, 2014, NAT MED
[79]   Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line [J].
Ren, Jin ;
Chen, Yitian ;
Song, Haizhu ;
Chen, Longbang ;
Wang, Rui .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (06) :1395-1403
[80]   Genetics and biomarkers in personalisation of lung cancer treatment [J].
Rosell, Rafael ;
Bivona, Trever G. ;
Karachaliou, Niki .
LANCET, 2013, 382 (9893) :720-731
3456789101112